Literature DB >> 31990691

Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.

W Glenn McCluggage1, Maria Apellaniz-Ruiz2,3, Anne-Laure Chong2,3, Krisztina Z Hanley4, Jose E Velázquez Vega5, Terri P McVeigh6, William D Foulkes2,3.   

Abstract

DICER1 mutations (somatic or germline) are associated with a variety of uncommon neoplasms including cervical and genitourinary embryonal rhabdomyosarcoma (ERMS). We report a primary ovarian and 2 primary fallopian tube ERMS occurring in 60-, 13-, and 14-year-olds, respectively. The 3 neoplasms exhibited a similar morphologic appearance being polypoid and containing edematous hypocellular areas and hypercellular foci composed of small cells with scant cytoplasm exhibiting rhabdomyoblastic differentiation (desmin, myogenin, myoD1 positive). There was cellular cartilage in all cases and extensive foci of anaplasia, eosinophilic globules, and bone/osteoid in 1 case each. All 3 neoplasms exhibited DICER1 mutations; in 1 of the tubal cases, the patient had a germline mutation and in the other 2 cases, the DICER1 mutations were somatic. Accompanying DICER1 "second hits" were identified in all cases. In 2 of the neoplasms, SALL4-positive glandular structures were present which we speculate may represent an unusual primitive "metaplastic" phenomenon. Our study adds to the literature on ERMS at unusual sites associated with DICER1 mutations. ERMS arising at such sites, especially when they contain cartilage or bone/osteoid, are especially likely to be associated with DICER1 mutations. Pathologists should be aware of this as these may be the sentinel neoplasms in patients with DICER1 syndrome and confirming a germline mutation can facilitate the screening of the individual and affected family members for other neoplasms which occur in this syndrome.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31990691     DOI: 10.1097/PAS.0000000000001442

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  DICER1-Associated Anaplastic Sarcoma of the Kidney With Coexisting Activating PDGFRA D842V Mutations and Response to Targeted Kinase Inhibitors in One Patient.

Authors:  Cristina R Antonescu; Victor E Reuter; Mary Lou Keohan; Sinchun Hwang; Ping Chi
Journal:  JCO Precis Oncol       Date:  2022-07

2.  Phenotypic similarities within the morphologic spectrum of DICER1-associated sarcomas and pleuropulmonary blastoma: Histopathologic features guide diagnosis in the LMIC setting.

Authors:  Paromita Roy; Anirban Das; Angad Singh; Joyshree Panda; Arpita Bhattacharya; Anisha Gehani; Mayur Parihar; Reghu K S; Rimpa Achari; Rita Alaggio; Amanda Field; D Ashley Hill; Louis P Dehner; Kris Ann P Schultz
Journal:  Pediatr Blood Cancer       Date:  2021-12-16       Impact factor: 3.838

3.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

4.  Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup.

Authors:  Andreas von Deimling; Christian Koelsche; Felix K F Kommoss; Damian Stichel; Jaume Mora; Manel Esteller; David T W Jones; Stefan M Pfister; Eva Brack; Marco Wachtel; Peter Karl Bode; Hans-Peter Sinn; Dietmar Schmidt; Thomas Mentzel; Friedrich Kommoss; Felix Sahm
Journal:  Mod Pathol       Date:  2021-04-12       Impact factor: 7.842

5.  Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.

Authors:  Charles W Ashley; Arnaud Da Cruz Paula; Lorenzo Ferrando; Rodrigo Gularte-Mérida; Ana P M Sebastiao; David N Brown; Andrea M Gazzo; Fresia Pareja; Anthe Stylianou; Nadeem R Abu-Rustum; Jorge S Reis-Filho; Darya Buehler; Paul Weisman; Sarah Chiang; Britta Weigelt
Journal:  Histopathology       Date:  2021-04-19       Impact factor: 7.778

6.  Malignant teratoid tumor of the thyroid gland: an aggressive primitive multiphenotypic malignancy showing organotypical elements and frequent DICER1 alterations-is the term "thyroblastoma" more appropriate?

Authors:  Abbas Agaimy; Leora Witkowski; Robert Stoehr; Joseph Christopher Castillo Cuenca; Carlos Alberto González-Muller; Alfred Brütting; Markus Bährle; Konstantinos Mantsopoulos; Randa M S Amin; Arndt Hartmann; Markus Metzler; Samir S Amr; William D Foulkes; Manuel Sobrinho-Simões; Catarina Eloy
Journal:  Virchows Arch       Date:  2020-06-07       Impact factor: 4.064

7.  Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.

Authors:  Shuyang Zhang; Huihui Yin; Jing Zhang; Lu Yang; Guangjian Yang; Jia Jia; Yuchen Jiao; Jianming Ying; Yan Wang
Journal:  Thorac Cancer       Date:  2021-08-31       Impact factor: 3.500

Review 8.  DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.

Authors:  Iván A González; Douglas R Stewart; Kris Ann P Schultz; Amanda P Field; D Ashley Hill; Louis P Dehner
Journal:  Mod Pathol       Date:  2021-10-01       Impact factor: 7.842

Review 9.  Genetic Predisposition to Solid Pediatric Cancers.

Authors:  Mario Capasso; Annalaura Montella; Matilde Tirelli; Teresa Maiorino; Sueva Cantalupo; Achille Iolascon
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

Review 10.  The clinical impact of intra- and extracellular miRNAs in ovarian cancer.

Authors:  Kosuke Yoshida; Akira Yokoi; Tomoyasu Kato; Takahiro Ochiya; Yusuke Yamamoto
Journal:  Cancer Sci       Date:  2020-08-27       Impact factor: 6.716

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.